We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
-$122M
Cap. Flow
+$39.1M
Cap. Flow %
1.93%
Top 10 Hldgs %
86.93%
Holding
129
New
23
Increased
19
Reduced
34
Closed
37

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$144M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$89.6M
3
ARQT icon
Arcutis Biotherapeutics
ARQT
+$8.13M
4
DXCM icon
DexCom
DXCM
+$7.8M
5
RMD icon
ResMed
RMD
+$7.26M

Top Sells

Rank Stock Value
1
MTBA icon
Simplify MBS ETF
MTBA
+$55.3M
2
SCHP icon
Schwab US TIPS ETF
SCHP
+$38.1M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$25M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$19.6M
5
ZTS icon
Zoetis
ZTS
+$11.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 89.55%
2 Healthcare 7.7%
3 Energy 1.16%
4 Industrials 0.75%
5 Consumer Discretionary 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXTV
76
DELISTED
Simplify Next Intangible Value Index ETF
NXTV
$681K 0.03%
26,999
-4,522
-14% -$125K
ARR
77
Armour Residential REIT
ARR
$2.31B
$519K 0.03%
27,500
+2,500
+10% +$48K
LIVN icon
78
LivaNova
LIVN
$4.51B
$435K 0.02%
9,397
-4,949
-34% -$254K
SYK icon
79
Stryker
SYK
$116B
$434K 0.02%
1,206
-606
-33% -$225K
JSPR icon
80
Jasper Therapeutics
JSPR
$23.6M
$428K 0.02%
+20,000
New +$416K
CVS icon
81
CVS Health
CVS
$124B
$409K 0.02%
+9,114
New +$511K
FULC icon
82
Fulcrum Therapeutics
FULC
$294M
$379K 0.02%
80,714
-270,600
-77% -$998K
CIM
83
Chimera Investment
CIM
$974M
$360K 0.02%
25,700
+15,700
+157% +$235K
TGTX icon
84
TG Therapeutics
TGTX
$8.57B
$338K 0.02%
+11,237
New +$322K
DHR icon
85
Danaher
DHR
$146B
$313K 0.02%
1,365
-707
-34% -$174K
CEE
86
Central and Eastern Europe Fund
CEE
$132M
$265K 0.01%
24,235
– –
ZBH icon
87
Zimmer Biomet
ZBH
$18.7B
$244K 0.01%
2,307
-1,228
-35% -$132K
AGL icon
88
Agilon Health
AGL
$1.49B
$210K 0.01%
4,421
-2,327
-34% -$141K
DCTH icon
89
Delcath Systems
DCTH
$572M
$205K 0.01%
+17,000
New +$179K
QVCGA
90
DELISTED
QVC Group Inc Series A
QVCGA
$198K 0.01%
12,000
+5,000
+71% +$117K
TWO
91
DELISTED
Two Harbors Investment
TWO
$130K 0.01%
11,000
+1,000
+10% +$12.1K
CMPS
92
Compass Pathways
CMPS
$1.84B
$53.9K ﹤0.01%
+14,248
New +$72.2K
AAPL icon
93
Apple
AAPL
$4.67T
– –
-997
Closed -$232K
ABBV icon
94
AbbVie
ABBV
$453B
– –
-47,252
Closed -$9.33M
AMD icon
95
Advanced Micro Devices
AMD
$780B
– –
-3,586
Closed -$588K
AMZN icon
96
Amazon
AMZN
$2.79T
– –
-1,185
Closed -$221K
ASML icon
97
ASML
ASML
$659B
– –
-250
Closed -$208K
AVTR icon
98
Avantor
AVTR
$10.1B
– –
-84,678
Closed -$2.19M
BIIB icon
99
Biogen
BIIB
$32.6B
– –
-2,470
Closed -$479K
BMRN icon
100
BioMarin Pharmaceuticals
BMRN
$12.9B
– –
-8,489
Closed -$597K
2 3
4
5 6

Similar funds

CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $7.18B AUM 18.15% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $7.25B AUM 33.76% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Simplify Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Simplify Asset Management held 129 positions worth $2.02B, down 5.7% from $2.15B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Simplify Asset Management's Q4 2024 filing shows 23 new, 19 increased, 34 reduced and 37 closed positions. Its largest new stake was Arcutis Biotherapeutics: 742,299 shares worth $10.3M. The largest sale was Simplify MBS ETF, an estimated $55.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, up from 85% a quarter earlier, followed by Healthcare and Energy.

  • Simplify Asset Management's largest Q4 2024 buy was Arcutis Biotherapeutics: 742,299 shares worth $10.3M.
  • Simplify Asset Management added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $144M increase.
  • Simplify Asset Management's biggest Q4 2024 reduction was Sarepta Therapeutics, cutting an estimated $19.6M.
  • Simplify Asset Management fully exited Simplify MBS ETF in Q4 2024, selling an estimated $55.3M.
  • Simplify Asset Management's ten largest holdings make up 87% of its $2.02B portfolio in Q4 2024.
  • Simplify Asset Management opened 23 new positions and closed 37 in Q4 2024.
  • Simplify Asset Management's portfolio value fell 5.7% quarter-over-quarter to $2.02B.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.